Clinical trial · Interventional
Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
NCT05440760CI-TRIAL-00109883recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective is to demonstrate the feasibility of incorporating VR distraction into the brachytherapy and radiotherapy clinical workflow. The secondary objective is to determine if VR distraction during brachytherapy treatment for cervical cancer improves subjects' satisfaction, procedural/acute pain, and need for analgesics or anxiolytics.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endocervical Cancer | Cervical Adenocarcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| The Oculus Quest 2 Virtual Reality Headset | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Sequence Group A
- description
- VR distraction occurring visits 1 and 2 with normal SOC therapy at visits 3 and 4.
- interventionNames
- Device: The Oculus Quest 2 Virtual Reality Headset
- type
- EXPERIMENTAL
- label
- Sequence Group B
- description
- VR distraction occurring visits 1 and 4 with normal SOC therapy at visits 2 and 3.
- interventionNames
- Device: The Oculus Quest 2 Virtual Reality Headset
- type
- EXPERIMENTAL
- label
- Sequence Group C
- description
- VR distraction occurring visits 3 and 4 with normal SOC therapy at visits 1 and 2.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female, ≥ 18 years of age * Histopathologic diagnosis of gynecologic cancer (endometrial, cervical, vaginal, vulvar) that requires intracavitary brachytherapy with a tandem or interstitial brachytherapy * Able to provide written consent Exclusion Criteria: * Severe vision or hearing problems that may hinder the ability to see or hear clearly through the VR headset or other condition that may interfere with the placement of the VR headset such as a head, ear or facial wound * History of seizure disorder, severe motion sickness, dizziness, or migraine headaches precipitated by visual auras * Known history of elevated intraocular pressure * Claustrophobia, thalassophobia, cleithrophobia or similar phobias * Any other significant medical or psychiatric conditions which, in the opinion of the enrolling investigator, may interfere with consent or compliance of the treatment regimen
References
Publications (0)
Data not yet available
No reference posted for this study.